Deep Vein Thrombosis, or DVT, is a serious condition where blood clots form in the deep veins, usually in the leg. These clots can break loose and travel through the bloodstream, causing life-threatening complications such as a pulmonary embolism. The DVT-Deep Vein Thrombosis Panel is a comprehensive set of blood tests that help in the assessment of the risk and the diagnosis of DVT.
This panel ../includes tests for Factor VIII, Activity of Antithrombin-III, Protein C, Free Protein S antigen, Lupus Anticoagulant (dRVVT), Cardiolipin IgG and IgM, and Beta2 glycoprotein IgG & IgM. Each of these tests provides vital information regarding blood clotting factors and proteins, which can be altered in individuals at risk for DVT.
Profile Name DVT-Deep Vein Thrombosis Panel
Sample Type Blood
Preparations Required No special preparation is required for this test. However, it is recommended to inform your doctor about any medications or supplements you are currently taking, as they may interfere with the test results.
Report Time 5 days
What is the purpose of the DVT-Deep Vein Thrombosis Panel?
The panel is used to assess the risk of developing DVT, diagnose DVT, and to identify potential underlying causes of abnormal blood clotting, which could lead to DVT.
Why is Factor VIII included in this panel?
Factor VIII is a blood clotting factor. High levels of Factor VIII can increase the risk of excessive clotting, hence it is tested to see if it is contributing to the risk of DVT.
Home Sample Collection Process
1
Book your convenient slot
2
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
4
Download Reports
Note: Home Sample Collection is only for Pathology lab tests.
Frequently Asked Questions
Antithrombin-III is a protein that helps regulate blood clotting. A deficiency in Antithrombin-III can cause excessive clotting, increasing the risk of DVT.
Protein C and Protein S are proteins that help prevent blood clotting. Low levels of these proteins can lead to an increased risk of forming blood clots and therefore, DVT.
Lupus Anticoagulant is an antibody that increases the risk of blood clotting. It is tested to determine if an autoimmune disorder is contributing to an increased risk of DVT.
These are antibodies that can be associated with blood clotting disorders. High levels may indicate an increased risk of DVT in individuals with autoimmune disorders like antiphospholipid syndrome.
A blood sample is drawn from a vein in the arm. This sample is then sent to the laboratory for analysis.
Yes, medications, especially anticoagulants or blood thinners, can affect the results of this panel. It's important to inform the doctor of any medications you are taking.
If the results indicate an increased risk of DVT, it's important to consult your doctor for further evaluation and management.
Yes, maintaining a healthy weight, staying active, not smoking, and managing underlying conditions such as high blood pressure can reduce the risk of DVT.
Yes, the DVT panel can be used to monitor the effectiveness of treatment for DVT and to adjust medication dosages if necessary.
No, this test can also be used for individuals who may be at risk for DVT due to family history or other risk factors, even if they do not have symptoms.
Symptoms of DVT may include swelling, pain, tenderness, and red or discolored skin in the affected limb, usually the leg.
If your test results are abnormal, you should consult your primary care doctor, who may refer you to a hematologist or vascular specialist for further evaluation and treatment.
Untreated DVT can lead to serious complications such as pulmonary embolism, post-thrombotic syndrome, and chronic thromboembolic pulmonary hypertension.
The DVT-Deep Vein Thrombosis Panel is an essential tool in the assessment and diagnosis of Deep Vein Thrombosis. This comprehensive set of tests can help identify underlying blood clotting disorders or other factors that may increase the risk of DVT. It is crucial to take proactive steps in managing risk factors and adhering to a treatment plan if diagnosed with DVT to avoid potentially life-threatening complication
